The DOI matches its OpenAlex record; 146 of the 146 references it cites were found in a registry or an index.
Vaccines for preventing rotavirus diarrhoea: vaccines in use
Open accessAbstract
BACKGROUND: Rotavirus is a common cause of diarrhoea, diarrhoea-related hospital admissions, and diarrhoea-related deaths worldwide. Rotavirus vaccines prequalified by the World Health Organization (WHO) include Rotarix (GlaxoSmithKline), RotaTeq (Merck), and, more recently, Rotasiil (Serum Institute of India Ltd.), and Rotavac (Bharat Biotech Ltd.). OBJECTIVES: To evaluate rotavirus vaccines prequalified by the WHO for their efficacy and safety in children. SEARCH METHODS: On 30 November 2020, we searched PubMed, the Cochrane Infectious Diseases Group Specialized Register, CENTRAL (published in the Cochrane Library), Embase, LILACS, Science Citation Index Expanded, Social Sciences Citation Index, Conference Proceedings Citation Index-Science, Conference Proceedings Citation Index-Social Science & Humanities. We also searched the WHO ICTRP, ClinicalTrials.gov, clinical trial reports from manufacturers' websites, and reference lists of included studies, and relevant systematic reviews. SELECTION CRITERIA: We selected randomized controlled trials (RCTs) conducted in children that compared rotavirus vaccines prequalified for use by the WHO with either placebo or no intervention. DATA COLLECTION AND ANALYSIS: Two authors independently assessed trial eligibility and assessed risk of bias. One author extracted data and a second author cross-checked them. We combined dichotomous data using the risk ratio (RR) and 95% confidence interval (CI). We stratified the analyses by under-five country mortality rate and used GRADE to evaluate evidence certainty. MAIN RESULTS: Sixty trials met the inclusion criteria and enrolled a total of 228,233 participants. Thirty-six trials (119,114 participants) assessed Rotarix, 15 trials RotaTeq (88,934 participants), five trials Rotasiil (11,753 participants), and four trials Rotavac (8432 participants). Rotarix Infants vaccinated and followed up for the first year of life In low-mortality countries, Rotarix prevented 93% of severe rotavirus diarrhoea cases (14,976 participants, 4 trials; high-certainty evidence), and 52% of severe all-cause diarrhoea cases (3874 participants, 1 trial; moderate-certainty evidence). In medium-mortality countries, Rotarix prevented 79% of severe rotavirus diarrhoea cases (31,671 participants, 4 trials; high-certainty evidence), and 36% of severe all-cause diarrhoea cases (26,479 participants, 2 trials; high-certainty evidence). In high-mortality countries, Rotarix prevented 58% of severe rotavirus diarrhoea cases (15,882 participants, 4 trials; high-certainty evidence), and 27% of severe all-cause diarrhoea cases (5639 participants, 2 trials; high-certainty evidence). Children vaccinated and followed up for two years In low-mortality countries, Rotarix prevented 90% of severe rotavirus diarrhoea cases (18,145 participants, 6 trials; high-certainty evidence), and 51% of severe all-cause diarrhoea episodes (6269 participants, 2 trials; moderate-certainty evidence). In medium-mortality countries, Rotarix prevented 77% of severe rotavirus diarrhoea cases (28,834 participants, 3 trials; high-certainty evidence), and 26% of severe all-cause diarrhoea cases (23,317 participants, 2 trials; moderate-certainty evidence). In high-mortality countries, Rotarix prevented 35% of severe rotavirus diarrhoea cases (13,768 participants, 2 trials; moderate-certainty evidence), and 17% of severe all-cause diarrhoea cases (2764 participants, 1 trial; high-certainty evidence). RotaTeq Infants vaccinated and followed up for the first year of life In low-mortality countries, RotaTeq prevented 97% of severe rotavirus diarrhoea cases (5442 participants, 2 trials; high-certainty evidence). In medium-mortality countries, RotaTeq prevented 79% of severe rotavirus diarrhoea cases (3863 participants, 1 trial; low-certainty evidence). In high-mortality countries, RotaTeq prevented 57% of severe rotavirus diarrhoea cases (6775 participants, 2 trials; high-certainty evidence), but there is probably little or no difference between vaccine and placebo for severe all-cause diarrhoea (1 trial, 4085 participants; moderate-certainty evidence). Children vaccinated and followed up for two years In low-mortality countries, RotaTeq prevented 96% of severe rotavirus diarrhoea cases (5442 participants, 2 trials; high-certainty evidence). In medium-mortality countries, RotaTeq prevented 79% of severe rotavirus diarrhoea cases (3863 participants, 1 trial; low-certainty evidence). In high-mortality countries, RotaTeq prevented 44% of severe rotavirus diarrhoea cases (6744 participants, 2 trials; high-certainty evidence), and 15% of severe all-cause diarrhoea cases (5977 participants, 2 trials; high-certainty evidence). We did not identify RotaTeq studies reporting on severe all-cause diarrhoea in low- or medium-mortality countries. Rotasiil Rotasiil has not been assessed in any RCT in countries with low or medium child mortality. Infants vaccinated and followed up for the first year of life In high-mo
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Borenstein, M., Hedges, L. V., Higgins, J. P. T., & Rothstein, H. R. (2009) · doi:10.1002/9780470743386 · Cited by 14,225
Borenstein, M., Hedges, L. V., Higgins, J. P. T., & Rothstein, H. R. (2021) · doi:10.1002/9781119558378 · Cited by 9,799
(2008) · Cited by 3,790
Global Illness and Deaths Caused by Rotavirus Disease in Children
Parashar, U. D., Hummelman, E. G., Bresee, J. S., Miller, M. A., & Glass, R. I. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0905.020562 · Cited by 1,898
Safety and Efficacy of a Pentavalent Human–Bovine (WC3) Reassortant Rotavirus Vaccine
Vesikari, T., Matson, D. O., Dennehy, P., Van Damme, P., Santosham, M., Rodriguez, Z., Dallas, M. J., Heyse, J. F., Goveia, M. G., Black, S. B., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052664 · Cited by 1,873
Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis
Ruiz-Palacios, G. M., Pérez-Schael, I., Velázquez, F. R., Abate, H., Breuer, T., Clemens, S. C., Cheuvart, B., Espinoza, F., Gillard, P., Innis, B. L., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052434 · Cited by 1,799
Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Harpaz, R., Ortega‐Sanchez, I. R., & Seward, J. F. (2008) · Cited by 1,302
Tate, J. E., Burton, A. H., Boschi-Pinto, C., Steele, A. D., Duque, J., & Parashar, U. D. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70253-5 · Cited by 1,277
Santos, N., & Hoshino, Y. (2005) · Reviews in Medical Virology · doi:10.1002/rmv.448 · Cited by 1,251
Published by John Wiley & Sons Ltd
Modarresi, O. A. F., & Shakibaie, M. M. M. R. (2015) · Cited by 1,111
Intussusception among Infants Given an Oral Rotavirus Vaccine
Murphy, T. V., Gargiullo, P. M., Massoudi, M. S., Nelson, D. B., Jumaan, A. O., Okoro, C. A., Zanardi, L. R., Setia, S., Fair, E., LeBaron, C. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102223440804 · Cited by 973
Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants
Madhi, S. A., Cunliffe, N. A., Steele, D., Witte, D., Kirsten, M., Louw, C., Ngwira, B., Victor, J. C., Gillard, P. H., Cheuvart, B. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0904797 · Cited by 886
Self-citationChapter 12: Interpreting results and drawing conclusions
Schünemann, H. J., Oxman, A. D., Jonathan, J., & Glasziou, P. (2011) · Cited by 870
Zaman, K., Anh, D. D., Victor, J. C., Shin, S., Yunus, M., Dallas, M. J., Podder, G., Thiem, V. D., Mai, L. T. P., Luby, S. P., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60755-6 · Cited by 824
Ruuska, T., & Vesikari, T. (1990) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549009027046 · Cited by 714
Rotavirus infection in infants as protection against subsequent infections
(1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)80038-8 · Cited by 674
Armah, G. E., Sow, S. O., Breiman, R. F., Dallas, M. J., Tapia, M. D., Feikin, D. R., Binka, F. N., Steele, A. D., Laserson, K. F., Ansah, N. A., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60889-6 · Cited by 654
Vesikari, T., Karvonen, A., Prymula, R., Schuster, V, Tejedor, J., Cohen, R., Meurice, F., Han, H., Damaso, S., & Bouckenooghe, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61744-9 · Cited by 636
Gentsch, J. R., Laird, A. R., Bielfelt, B., Griffin, D. D., Bányai, K., Ramachandran, M., Jain, V., Cunliffe, N. A., Nakagomi, O., Kirkwood, C. D., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/431499 · Cited by 624
Self-citationYou, D., Hug, L., Ejdemyr, S., & Beise, J. (2015) · Cited by 563
Sudarshan, M. K., Madhusudana, S. N., Mahendra, B. J., Rao, N. S. N., Ashwath Narayana, D. H., Abdul Rahman, S., Meslin, F.-X., Lobo, D., Ravikumar, K., & Gangaboraiah (2007) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2005.10.007 · Cited by 433
Linhares, A. C., Velázquez, F. R., Pérez-Schael, I., Sáez-Llorens, X., Abate, H., Espinoza, F., López, P., Macías-Parra, M., Ortega-Barría, E., Rivera-Medina, D. M., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60524-3 · Cited by 379
Effect of Rotavirus Vaccination on Death from Childhood Diarrhea in Mexico
Richardson, V., Hernandez-Pichardo, J., Quintanar-Solares, M., Esparza-Aguilar, M., Johnson, B., Gomez-Altamirano, C. M., Parashar, U., & Patel, M. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0905211 · Cited by 373
Prymula, R., Siegrist, C.-A., Chlibek, R., Zemlickova, H., Vackova, M., Smetana, J., Lommel, P., Kaliskova, E., Borys, D., & Schuerman, L. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61208-3 · Cited by 372
Interpreting Results and Drawing Conclusions
Schünemann, H. J., Oxman, A. D., Vist, G. E., Higgins, J. P., Deeks, J. J., Glasziou, P., & Guyatt, G. H. (2008) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9780470712184.ch12 · Cited by 366
Bhandari, N., Rongsen-Chandola, T., Bavdekar, A., John, J., Antony, K., Taneja, S., Goyal, N., Kawade, A., Kang, G., Rathore, S. S., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62630-6 · Cited by 326
Intussusception Risk after Rotavirus Vaccination in U.S. Infants
Yih, W. K., Lieu, T. A., Kulldorff, M., Martin, D., McMahill-Walraven, C. N., Platt, R., Selvam, N., Selvan, M., Lee, G. M., & Nguyen, M. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1303164 · Cited by 318
Evaluation of the Impact of Hepatitis B Vaccination among Children Born during 1992–2005 in China
Liang, X., Bi, S., Yang, W., Wang, L., Cui, G., Cui, F., Zhang, Y., Liu, J., Gong, X., Chen, Y., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/599332 · Cited by 278
Levine, M. M. (2010) · BMC Biology · doi:10.1186/1741-7007-8-129 · Cited by 261
do Carmo, G. M. I., Yen, C., Cortes, J., Siqueira, A. A., de Oliveira, W. K., Cortez-Escalante, J. J., Lopman, B., Flannery, B., de Oliveira, L. H., Hage Carmo, E., et al. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001024 · Cited by 260
Bresee, J. S., Glass, R. I., Ivanoff, B., & Gentsch, J. R. (1999) · Vaccine · doi:10.1016/s0264-410x(98)00376-4 · Cited by 251
Jonesteller, C. L., Burnett, E., Yen, C., Tate, J. E., & Parashar, U. D. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix369 · Cited by 238
Oral Rotavirus Vaccines: How Well Will They Work Where They Are Needed Most?
Patel, M., Shane, A. L., Parashar, U. D., Jiang, B., Gentsch, J. R., & Glass, R. I. (2009) · The Journal of Infectious Diseases · doi:10.1086/605035 · Cited by 232
Bernstein, D. I., Sack, D. A., Rothstein, E., Reisinger, K., Smith, V. E., O'Sullivan, D., Spriggs, D. R., & Ward, R. L. (1999) · The Lancet · doi:10.1016/s0140-6736(98)12106-2 · Cited by 232
Risk of Intussusception after Monovalent Rotavirus Vaccination
Weintraub, E. S., Baggs, J., Duffy, J., Vellozzi, C., Belongia, E. A., Irving, S., Klein, N. P., Glanz, J. M., Jacobsen, S. J., Naleway, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1311738 · Cited by 223
Protective Effect of Natural Rotavirus Infection in an Indian Birth Cohort
Gladstone, B. P., Ramani, S., Mukhopadhya, I., Muliyil, J., Sarkar, R., Rehman, A. M., Jaffar, S., Gomara, M. I., Gray, J. J., Brown, D. W. G., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1006261 · Cited by 218
(2007) · PubMed · Cited by 215
Efficacy of RIX4414 Live Attenuated Human Rotavirus Vaccine in Finnish Infants
Vesikari, T., Karvonen, A., Puustinen, L., Zeng, S.-Q., Szakal, E. D., Delem, A., & De Vos, B. (2004) · Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000141722.10130.50 · Cited by 214
Causes of Impaired Oral Vaccine Efficacy in Developing Countries
Parker, E. P. K., Ramani, S., Lopman, B. A., Church, J. A., Iturriza-Gómara, M., Prendergast, A. J., & Grassly, N. C. (2018) · Future Microbiology · doi:10.2217/fmb-2017-0128 · Cited by 214
Correia, J. B., Patel, M. M., Nakagomi, O., Montenegro, F. M. U., Germano, E. M., Correia, N. B., Cuevas, L. E., Parashar, U. D., Cunliffe, N. A., & Nakagomi, T. (2010) · The Journal of Infectious Diseases · doi:10.1086/649843 · Cited by 207
Self-citationReal-world effectiveness of rotavirus vaccines, 2006–19: a literature review and meta-analysis
Burnett, E., Parashar, U. D., & Tate, J. E. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30262-x · Cited by 206
Malek, M. A., Curns, A. T., Holman, R. C., Fischer, T. K., Bresee, J. S., Glass, R. I., Steiner, C. A., & Parashar, U. D. (2006) · Pediatrics · doi:10.1542/peds.2005-2351 · Cited by 205
Global Seasonality of Rotavirus Disease
Patel, M. M., Pitzer, V. E., Alonso, W. J., Vera, D., Lopman, B., Tate, J., Viboud, C., & Parashar, U. D. (2013) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31827d3b68 · Cited by 204
The Development Of Multivalent Bovine Rotavirus (Strain Wc3) Reassortant
Clark, H. F., Offit, P. A., Ellis, R. W., Eiden, J. J., Krah, D., Shaw, A. R., Pichichero, M., Treanor, J. J., Borian, F. E., Bell, L. M., et al. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/174.supplement_1.s73 · Cited by 197
Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12
BERNSTEIN, D. (1998) · Vaccine · doi:10.1016/s0264-410x(97)00210-7 · Cited by 196
Carlin, J. B., Macartney, K. K., Lee, K. J., Quinn, H. E., Buttery, J., Lopert, R., Bines, J., & McIntyre, P. B. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit520 · Cited by 191
de Palma, O., Cruz, L., Ramos, H., de Baires, A., Villatoro, N., Pastor, D., de Oliveira, L. H., Kerin, T., Bowen, M., Gentsch, J., et al. (2010) · BMJ · doi:10.1136/bmj.c2825 · Cited by 184
Efficacy of a Low-Cost, Heat-Stable Oral Rotavirus Vaccine in Niger
Isanaka, S., Guindo, O., Langendorf, C., Matar Seck, A., Plikaytis, B. D., Sayinzoga-Makombe, N., McNeal, M. M., Meyer, N., Adehossi, E., Djibo, A., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1609462 · Cited by 178
Bar-Zeev, N., Kapanda, L., Tate, J. E., Jere, K. C., Iturriza-Gomara, M., Nakagomi, O., Mwansambo, C., Costello, A., Parashar, U. D., Heyderman, R. S., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)71060-6 · Cited by 174
Self-citationA Rotavirus Vaccine for Prophylaxis of Infants Against Rotavirus Gastroenteritis
De Vos, B., Vesikari, T., Linhares, A. C., Salinas, B., Pérez-Schael, I., Ruiz-Palacios, G. M., Guerrero, M. D. L., Phua, K. B., Delem, A., & Hardt, K. (2004) · Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000142370.16514.4a · Cited by 167
Clark, H. F., Bernstein, D. I., Dennehy, P. H., Offit, P., Pichichero, M., Treanor, J., Ward, R. L., Krah, D. L., Shaw, A., Dallas, M. J., et al. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2003.10.054 · Cited by 166
Current and new rotavirus vaccines
Burke, R. M., Tate, J. E., Kirkwood, C. D., Steele, A. D., & Parashar, U. D. (2019) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000572 · Cited by 156
Prevention of Rotavirus Disease: Guidelines for Use of Rotavirus Vaccine
(1998) · PEDIATRICS · doi:10.1542/peds.102.6.1483 · Cited by 149
Groome, M. J., Koen, A. L., Fix, A. D., Page, N. A., Jose, L., Madhi, S. A., McNeal, M., Dally, L., Cho, I., Power, M. E., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30242-6 · Cited by 148
Rotavirus Vaccines: Targeting the Developing World
Glass, R. I., Bresee, J., Turcios, R. M., Fischer, T. K., Parashar, U. D., & Steele, A. D. (2005) · The Journal of Infectious Diseases · doi:10.1086/431504 · Cited by 147
Cunliffe, N. A., Witte, D., Ngwira, B. M., et al. (2012) · Vaccine · doi:10.1016/j.vaccine.2011.09.120 · Cited by 145
Self-citationKulkarni, P. S., Desai, S., Tewari, T., Kawade, A. S., Goyal, N. P., Garg, B., Kumar, D., Kanungo, S., Kamat, V., Kang, G., et al. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.09.014 · Cited by 144
Groome, M. J., Page, N. A., Cortese, M. M., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70940-5 · Cited by 134
Clark, A. D., van Zandvoort, K., Flasche, S., Sanderson, C. F. B., Bines, J. E., Tate, J. E., Parashar, U. D., & Jit, M. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30126-4 · Cited by 128
Lamberti, L. M., Ashraf, S., Walker, C. L. F., & Black, R. E. (2016) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001232 · Cited by 127
Phua, K. B., Quak, S. H., Lee, B. W., Emmanuel, S. C., Goh, P. S. C., Han, H. H., Vos, B. D., & Bock, H. L. (2005) · The Journal of Infectious Diseases · doi:10.1086/431511 · Cited by 126
Parker, E. P. K., Praharaj, I., Zekavati, A., Lazarus, R. P., Giri, S., Operario, D. J., Liu, J., Houpt, E. R., Iturriza‐Gómara, M., Kampmann, B., et al. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.11.031 · Cited by 124
Goveia, M. G., Rodriguez, Z. M., Dallas, M. J., Itzler, R. F., Boslego, J. W., Heaton, P. M., & DiNubile, M. J. (2007) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31814521cb · Cited by 112
Vesikari, T., Damme, P. V., Giaquinto, C., Gray, J. J., Mrukowicz, J. Z., Dagan, R., Guarino, A., Szajewska, H., & Usonis, V. (2008) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31816f7a10 · Cited by 110
Zaman, K., Sack, D. A., Yunus, M., Arifeen, S. E., Podder, G., Azim, T., Luby, S. P., Breiman, R. F., Neuzil, K. M., Datta, S. K., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2008.12.059 · Cited by 109
Rotavirus vaccines: Current status and future considerations
Yen, C., Tate, J. E., Hyde, T. B., Cortese, M. M., Lopman, B. A., Jiang, B., Glass, R. I., & Parashar, U. D. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.28857 · Cited by 108
Kirkpatrick, B. D., Colgate, E. R., Mychaleckyj, J. C., Haque, R., Dickson, D. M., Carmolli, M. P., Nayak, U., Taniuchi, M., Naylor, C., Qadri, F., et al. (2015) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.14-0518 · Cited by 105
Bhandari, N., Rongsen‐Chandola, T., Bavdekar, A., John, J. K., Antony, K., Taneja, S., Goyal, N. P., Kawade, A. S., Kang, G., Rathore, S. S., et al. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.04.079 · Cited by 102
Dennehy, P. H., Brady, R. C., Halperin, S. A., Ward, R. L., Alvey, J. C., Fischer, F. H., Innis, B. L., Rathfon, H., Schuind, A., & Vos, B. D. (2005) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000164763.55558.71 · Cited by 101
Evaluation of Intussusception after Monovalent Rotavirus Vaccination in Africa
Tate, J. E., Mwenda, J. M., Armah, G. E., Jani, B., Omore, R., Ademe, A., Mujuru, H. A., Mpabalwani, E. M., Ngwira, B. M., Cortese, M. M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1713909 · Cited by 101
Self-citationVaccines for preventing rotavirus diarrhoea: vaccines in use
Soares‐Weiser, K., MacLehose, H. G., Bergman, H., Ben‐Aharon, I., Nagpal, S., Goldberg, E., Pitan, F., & Cunliffe, N. A. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008521.pub2 · Cited by 96
Self-citationLazarus, R. P., John, J. K., Shanmugasundaram, E., Kasirajan, A., Thiagarajan, S., Giri, S., Babji, S., Sarkar, R., Kaliappan, S. P., Venugopal, S., et al. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.07.116 · Cited by 86
Invasive non-typhoidal salmonellosis in immunocompetent infants and children
Galanakis, E., Bitsori, M., Maraki, S., Giannakopoulou, C. C., Samonis, G., & Tselentis, Y. (2006) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2005.09.004 · Cited by 84
Rongsen‐Chandola, T., Strand, T. A., Goyal, N. P., Flem, E., Rathore, S. S., Arya, A., Winje, B. A., Lazarus, R. P., Shanmugasundaram, E., Babji, S., et al. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.04.078 · Cited by 84
Removing the Age Restrictions for Rotavirus Vaccination: A Benefit-Risk Modeling Analysis
Patel, M. M., Clark, A. D., Sanderson, C. F. B., Tate, J. E., & Parashar, U. D. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001330 · Cited by 84
The New Pentavalent Rotavirus Vaccine Composed of Bovine (Strain WC3) -Human Rotavirus Reassortants
Clark, H. F., Offit, P. A., Plotkin, S. A., & Heaton, P. M. (2006) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000220283.58039.b6 · Cited by 83
Velázquez, F. R., Linhares, A. C., Muñoz, S., Pamela Serón, S., Lorca, P., DeAntonio, R., & Ortega‐Barría, E. (2017) · BMC Pediatrics · doi:10.1186/s12887-016-0771-y · Cited by 83
Lee, B., Dickson, D. M., deCamp, A. C., Colgate, E. R., Diehl, S. A., Uddin, M. I., Sharmin, S., Islam, S., Bhuiyan, T. R., Alam, M., et al. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy054 · Cited by 83
Vaccines against enteric infections for the developing world
Czerkinsky, C. C., & Holmgren, J. R. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2015.0142 · Cited by 82
The effect of rotavirus vaccine on diarrhoea mortality
Munos, M. K., Walker, C. L. F., & Black, R. E. (2010) · International Journal of Epidemiology · doi:10.1093/ije/dyq022 · Cited by 82
Rivera, L. E., Peña, L., Stainier, I., Gillard, P. H., Cheuvart, B., Smolenov, I. V., Ortega‐Barría, E., & Han, H. H. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.10.015 · Cited by 80
Groome, M. J., Fairlie, L., Morrison, J. L., Fix, A. D., Koen, A. L., Masenya, M., Jose, L., Madhi, S. A., Page, N. A., McNeal, M., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30001-3 · Cited by 79
Hemming‐Harlo, M., Lähdeaho, M., Mäki, M., & Vesikari, T. (2019) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000002281 · Cited by 77
Efficacy of the Human Rotavirus Vaccine RIX4414 in Malnourished Children
Pérez‐Schael, I., Salinas, B., Tomat, M. F., Linhares, A. C., Guerrero, M. L., Ruiz-Palacios, G. M., Bouckenooghe, A. R., & Yarzábal, J. P. (2007) · The Journal of Infectious Diseases · doi:10.1086/519687 · Cited by 76
Bhandari, N., Sharma, P., Glass, R. I., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.001 · Cited by 75
MedDRA (Medical Dictionary for Regulatory Activities)
Jaasu, N. M., Kamaraj, R., & Seetharaman, R. (2018) · Research Journal of Pharmacy and Technology · doi:10.5958/0974-360x.2018.00866.1 · Cited by 73
(2012) · PubMed · Cited by 72
Colgate, E. R., Haque, R., Dickson, D. M., Carmolli, M. P., Mychaleckyj, J. C., Nayak, U., Qadri, F., Alam, M., Walsh, M. C., Diehl, S. A., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw346 · Cited by 70
Emperador, D., Velásquez, D. E., Estívariz, C. F., Lopman, B. A., Jiang, B., Parashar, U. D., Anand, A., & Zaman, K. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ807 · Cited by 69
Steele, A. D., Madhi, S. A., Louw, C. E., et al. (2010) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181f42db9 · Cited by 68
Clark, H. F., Burke, C. J., Volkin, D. B., Offit, P. A., Ward, R. L., Bresee, J., Dennehy, P. H., Gooch, W. M., Malacaman, E. A., Matson, D., et al. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000091887.48999.77 · Cited by 67
Dellepiane, N., & Wood, D. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.11.066 · Cited by 66
The impact of rotavirus gastroenteritis on the family
Mast, T. C., DeMuro, C., Kelly, C. M., Floyd, L. E., & Walter, E. B. (2009) · BMC Pediatrics · doi:10.1186/1471-2431-9-11 · Cited by 65
Bucardo, F., Nordgren, J., Reyes, Y. I., González, F., Sharma, S., & Svensson, L. (2018) · Scientific Reports · doi:10.1038/s41598-018-19718-y · Cited by 65
Phua, K. B., Lim, F. S., Lau, Y., Nelson, E. A. S., Huang, L., Quak, S. H., Lee, B. W., Doorn, L. J. V., Teoh, Y. L., Tang, H., et al. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.03.030 · Cited by 64
Clark, A. D., Tate, J. E., Parashar, U. D., Jit, M., Hasso-Agopsowicz, M., Henschke, N., Lopman, B. A., van Zandvoort, K., Pecenka, C. J., Fine, P., et al. (2019) · The Lancet Global Health · doi:10.1016/s2214-109x(19)30412-7 · Cited by 63
Rotavirus vaccine and diarrhea mortality: quantifying regional variation in effect size
Walker, C. L. F., & Black, R. E. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-s3-s16 · Cited by 61
Efficacy of the oral pentavalent rotavirus vaccine in Mali
Sow, S. O., Tapia, M. D., Haidara, F. C., Ciarlet, M., Diallo, F., Kodio, M., Doumbia, M. M., Dembelé, R., Traoré, O., Onwuchekwa, U. U., et al. (2012) · Vaccine · doi:10.1016/j.vaccine.2011.11.094 · Cited by 61
Immunogenicity of the pentavalent rotavirus vaccine in African infants
Armah, G. E., Breiman, R. F., Tapia, M. D., Dallas, M. J., Neuzil, K. M., Binka, F. N., Sow, S. O., Ojwando, J., Ciarlet, M., & Steele, A. D. (2012) · Vaccine · doi:10.1016/j.vaccine.2011.10.006 · Cited by 57
Armah, G. E., Lewis, K. D. C., Cortese, M. M., et al. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw023 · Cited by 56
Product review of the rotavirus vaccines ROTASIIL, ROTAVAC, and Rotavin-M1
Skansberg, A., Sauer, M. A., Tan, M., Santosham, M., & Jennings, M. C. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1804245 · Cited by 55
Dutta, P., Mitra, U., Dutta, S., Rajendran, K., Saha, T. K., & Chatterjee, M. K. (2011) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2011.02745.x · Cited by 53
Dennehy, P. H., Bertrand, H. R., Silas, P. E., Damaso, S., Friedland, L. R., & Abu‐Elyazeed, R. (2008) · PEDIATRICS · doi:10.1542/peds.2008-1059 · Cited by 52
Muhsen, K., Shulman, L. M., Kasem, E., Rubinstein, U., Shachter, J., Kremer, A., Goren, S., Zilberstein, I., Chodick, G., Ephros, M. A., et al. (2010) · Human Vaccines · doi:10.4161/hv.6.6.11759 · Cited by 51
Ward, R. L., Bernstein, D. I., Smith, V. E., Sander, D. S., SHAW, A. R., Eiden, J., Heaton, P. M., Offit, P. A., & Clark, H. F. (2004) · The Journal of Infectious Diseases · doi:10.1086/421248 · Cited by 51
McQuade, E. T. R., Platts-Mills, J. A., Colgate, E. R., Haque, R., Zaman, K., Petri, W. A., & Kirkpatrick, B. D. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix668 · Cited by 51
Bar‐Zeev, N., King, C., Phiri, T., Beard, J., Mvula, H., Crampin, A. C., Heinsbroek, E., Lewycka, S. O., Tate, J. E., Parashar, U. D., et al. (2018) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30314-0 · Cited by 50
Self-citationRotavirus vaccine for preventing diarrhoea
Soares‐Weiser, K., Goldberg, E., Tamimi, G., Leibovici, L., & Pitan, F. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002848.pub2 · Cited by 48
Self-citationVaccines for preventing rotavirus diarrhoea: vaccines in use
Soares‐Weiser, K., MacLehose, H. G., Ben‐Aharon, I., Goldberg, E., Pitan, F., & Cunliffe, N. A. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008521 · Cited by 48
Self-citationOptions for the Prevention of Rotavirus Disease Other Than Vaccination
Mrukowicz, J. Z., Szajewska, H., & Vesikari, T. (2008) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31816f79b0 · Cited by 46
Dose Response and Efficacy of a Live, Attenuated Human Rotavirus Vaccine in Mexican Infants
Ruiz-Palacios, G. M., Guerrero, M. L., Bautista-Márquez, A., et al. (2007) · PEDIATRICS · doi:10.1542/peds.2006-2630 · Cited by 45
Efficacy of pentavalent rotavirus vaccine in a high HIV prevalence population in Kenya
Feikin, D. R., Laserson, K. F., Ojwando, J., Nyambane, G., Ssempijja, V., Audi, A. O., Nyakundi, D., Oyieko, J. N., Dallas, M. J., Ciarlet, M., et al. (2012) · Vaccine · doi:10.1016/j.vaccine.2011.08.043 · Cited by 45
Rojas, O. L., Caicedo, L., Cruz, P. C. G., Rodríguez, L., Castañeda, J. S., Uribe, L., Andrade, Y., Pinzón, R., Narváez, C. F., Lozano, J. M., et al. (2007) · Viral Immunology · doi:10.1089/vim.2006.0105 · Cited by 44
Kapikian, A. Z., Flores, J., Midthun, K., Hoshino, Y., Green, K. Y., Gorziglia, M. I., Nishikawa, K., Chanock, R. M., Potash, L., & Pérez‐Schael, I. (1989) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-5712-4_9 · Cited by 43
Rotavirus Vaccine — A Powerful Tool to Combat Deaths from Diarrhea
Santosham, M. (2010) · New England Journal of Medicine · doi:10.1056/nejme0912141 · Cited by 38
Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules
Libster, R., McNeal, M., Walter, E. B., Shane, A. L., Winokur, P. L., Cress, G. A., Berry, A. A., Kotloff, K. L., Sarpong, K. O., Turley, C. B., et al. (2016) · PEDIATRICS · doi:10.1542/peds.2015-2603 · Cited by 38
Heylen, E., Zeller, M., Ciarlet, M., Lawrence, J., Steele, A. D., Ranst, M. A. V., & Matthijnssens, J. (2015) · Scientific Reports · doi:10.1038/srep14658 · Cited by 35
Laserson, K. F., Nyakundi, D., Feikin, D. R., Nyambane, G., Cook, E., Oyieko, J. N., Ojwando, J., Rivers, S. B., Ciarlet, M., Neuzil, K. M., et al. (2012) · Vaccine · doi:10.1016/j.vaccine.2011.09.026 · Cited by 32
Immunisation of the immunocompromised child
Pinto, M. V., Bihari, S., & Snape, M. D. (2016) · Journal of Infection · doi:10.1016/j.jinf.2016.04.017 · Cited by 32
Chandola, T. R., Taneja, S., Goyal, N. P., Antony, K., Bhatia, K., More, D., Bhandari, N., Cho, I., Surapaneni, K. M., Prasad, S. D., et al. (2017) · Heliyon · doi:10.1016/j.heliyon.2017.e00302 · Cited by 32
Rotavirus vaccines: entering a new stage of deployment
Nakagomi, O., & Cunliffe, N. A. (2007) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3282a56ba0 · Cited by 29
Self-citationLevin, M. J., Lindsey, J. C., Kaplan, S. S., Schimana, W., Lawrence, J., McNeal, M., Bwakura‐Dangarembizi, M., Ogwu, A., Mpabalwani, E. M., Sato, P., et al. (2016) · AIDS · doi:10.1097/qad.0000000000001258 · Cited by 28
Vesikari, T., Karvonen, A., Bouckenooghe, A. R., Suryakiran, P. V., Smolenov, I. V., & Han, H. H. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.01.004 · Cited by 25
Dhingra, M. S., Kundu, R., Gupta, M., Kanungo, S., Ganguly, N., Singh, M. P., Bhattacharya, M. K., Ghosh, R., Kumar, R., Sur, D., et al. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.03.069 · Cited by 24
Diness, B. R., Christoffersen, D., Pedersen, U. B., Rodrigues, A., Fischer, T. K., Andersen, A., Whittle, H. C., Yazdanbakhsh, M., Aaby, P., & Benn, C. S. (2010) · The Journal of Infectious Diseases · doi:10.1086/653569 · Cited by 22
Plosker, G. L. (2011) · PharmacoEconomics · doi:10.2165/11207210-000000000-00000 · Cited by 22
Introduction of rotavirus vaccines in developing countries: remaining challenges
Cunliffe, N. A., & Nakagomi, O. (2007) · Annals of Tropical Paediatrics · doi:10.1179/146532807x220262 · Cited by 20
Self-citationElla, R., Babji, S., Ciarlet, M., Blackwelder, W. C., & Vadrevu, K. M. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.05.069 · Cited by 17
Plosker, G. L. (2011) · PharmacoEconomics · doi:10.2165/11207130-000000000-00000 · Cited by 17
Saluja, T., Palkar, S. H., Misra, P., Gupta, M., Potula, V., Sood, A. K., Dhati, R. M., Shetty, A., Dhaded, S. M., Agarkhedkar, S., et al. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.05.019 · Cited by 16
Herrera, D., Vásquez, C., Corthésy, B., Franco, M. A., & Ángel, J. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.25610 · Cited by 15
Weinberg, A., Lindsey, J. C., Bosch, R. J., Persaud, D., Sato, P., Ogwu, A., Asmelash, A., Bwakura-Dangarambezi, M., Chi, B. H., Canniff, J. D., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.02002 · Cited by 15
Acute infectious pediatric gastroenteritis: beyond oral rehydration therapy
Freedman, S. B. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.11.1651 · Cited by 14
Tamminen, K., Heinimäki, S., Vesikari, T., & Blazevic, V. (2020) · Journal of Immunology Research · doi:10.1155/2020/3194704 · Cited by 14
Ustrup, M., Madsen, L. B., Bygbjerg, I. C., & Konradsen, F. (2011) · PubMed · Cited by 13
Selected Regulatory And Scientific Topics For Candidate Rotavirus Vaccine Development
Henchal, L. S., Midthun, K., & Goldenthal, K. L. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/174.supplement_1.s112 · Cited by 12
Projecting the effectiveness of RotaTeq® against rotavirus-related hospitalisations in Brazil
Khoury, A. C. E., Mast, T. C., Ciarlet, M., Markson, L. E., Goveia, M. G., Munford, V., & Rácz, M. L. (2011) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762011000500004 · Cited by 10
Aziz, A. B., Ali, M., Basunia, A.-U. H., Yunus, M., Clemens, J. D., & Zaman, K. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.01.041 · Cited by 10
Background rates of disease in Latin American children from a rotavirus vaccine study
Baay, M. F. D., Bollaerts, K., Struchiner, C. J., & Verstraeten, T. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1320007 · Cited by 7
Hitchings, M. D. T., Cummings, D. A. T., Grais, R. F., & Isanaka, S. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.10.079 · Cited by 7
de la Cueva, I. S., Pahud, B. A., Huang, L., Leonardi, M. L., García-Sicilia, J., Céspedes, J., Abdelnour, A., Tamura, T., Kuroki, H., Chiu, N., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa210 · Cited by 6
Gillard, P. H., Tamura, T., Kuroki, H., Morikawa, Y., Moerman, L., Parra, J., Kitamura, Y., Mihara, K., & Okamasa, A. (2019) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1564441 · Cited by 5
Abu‐Elyazeed, R., Klein, N. P., Moerman, L., Povey, M., Pruitt, A., Senders, S. D., Silas, P. E., Bi, D., Acevedo, A., Amisola, R., et al. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.08.070 · Cited by 4
Cited by
Hodgson, S. H., Mansatta, K., Mallett, G., Harris, V., Emary, K. R. W., & Pollard, A. J. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30773-8 · Cited by 633
Cumpston, M. S., McKenzie, J. E., Welch, V. A., & Brennan, S. E. (2022) · Journal of Public Health · doi:10.1093/pubmed/fdac036 · Cited by 464
Liévin-Le Moal, V., & Servin, A. L. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00080-13 · Cited by 354
Bhandari, N., Rongsen-Chandola, T., Bavdekar, A., John, J., Antony, K., Taneja, S., Goyal, N., Kawade, A., Kang, G., Rathore, S. S., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62630-6 · Cited by 326
Intussusception Risk after Rotavirus Vaccination in U.S. Infants
Yih, W. K., Lieu, T. A., Kulldorff, M., Martin, D., McMahill-Walraven, C. N., Platt, R., Selvam, N., Selvan, M., Lee, G. M., & Nguyen, M. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1303164 · Cited by 318
Metadata
- Authors
- Soares‐Weiser, K., MacLehose, H. G., Bergman, H., Ben‐Aharon, I., Nagpal, S., Goldberg, E., Pitan, F., & Cunliffe, N. A.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Elsevier BV
- Published
- 2012-11-09
- Volume
- 11
- Pages
- CD008521-CD008521
- ISSN
- 1361-6137 (ISSN-L)
- OpenAlex
- W2128322670
- Cited by
- 381
- References
- 146
- Type
- reference entry
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.